The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 135.00
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 10.00 (7.407%)
Open: 142.50
High: 142.50
Low: 140.00
Prev. Close: 140.00
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

26 Jan 2021 14:47

RNS Number : 9573M
Manolete Partners PLC
26 January 2021
 

26 January 2021

THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014 ("MAR").

Manolete Partners Plc

("Manolete" or the "Company")

Q3 Trading Update

 

Manolete Partners Plc (AIM: MANO), the leading listed insolvency litigation financing firm in the UK, announces record case completions and record completed case cash inflows but a continued low level of new case investments caused by the ongoing extraordinary UK Government economic support measures. All numbers in this document are unaudited and from internal Company sources.

As highlighted in the Company's interim results for the six months ended 30 September 2020 (announced 10 November 2020), new case enquiries had begun to slow sharply due to the extraordinary UK Government economic support measures that have directly led to a large decrease in the number of UK company insolvencies since the start of the Covid-19 pandemic. This has continued throughout Q3 and into the first few weeks of Q4. The Government measures are planned to continue through to April 2021 at least and so we expect the negative impact on the Company's level of new cases (which continue to be subject to our stringent levels of selection criteria) to persist for the remainder of the current financial year ending 31 March 2021.

In the third quarter of the Company's current financial year ending 31 March 2021, Manolete completed a further 43 insolvency litigation claims bringing the total for the nine months to 31 December 2020 to 95 completed cases. At the time of writing this has now risen to 108 completed cases. This is 100% higher than the 54 cases completions for the whole 12 months of the previous year ended 31 March 2020.

The 95 completed cases for the nine months to 31 December 2020 generated a gross total settlement value of [1]£23.9m, comfortably exceeding board expectations.

Gross cash collected from completed cases in the first nine months to 31 December 2020 increased by 60% to a record £9.3m (nine months ended 31 December 2019: £5.8m). After payments to Insolvent Estates and legal fees, the Company's retained share of this cash increased by 60% to £4.8m (nine months ended 31 December 2019: £3.0m). Cash overheads for the nine-month period were £3.2m (prior year nine-month period: £3.0m), resulting in a cash inflow after payment of operational overheads of £1.5m, compared to an outflow of £32k for the comparable prior year nine-month period. Gross cash generation in Q3 of £5.1m was particularly strong with cash generated from completed cases covering not only all completed case costs and all overheads but also all costs of around 250 ongoing live cases which are expected to generate very significant cash in the Company's normal timeframes.

As a consequence of the above factors, the Board expects realised profits to be above, but unrealised profits to be significantly below, market expectations and therefore for the Company to be overall marginally EBIT profitable in H2.

Longer term, the Board believes that as the UK Government economic support measures are phased out, the longer-term impact of COVID-19 on the UK economy will lead to an increased rate of corporate insolvencies, and will underpin the Company's strong growth prospects for the foreseeable future. The Board will continue to closely monitor the evolving situation and the impact on anticipated levels of litigation finance enquiries in and beyond the near term, and the naturally needed conservatism to be applied to fair values of ongoing cases.

Steven Cooklin, CEO of Manolete, commented: "As we highlighted in our recent interim results, the emergency UK Government actions in response to the pandemic have led to a dramatic decrease in the number of UK insolvencies. This has led to a distorted reality for the economy - many commentators, including last week the Federation for Small Businesses, have highlighted the very high levels of UK companies in significant financial distress. As a consequence, we have a temporary distortion in our new cases and therefore bottom-line profits, though an excellent performance in terms of case completions and strong cash generation. Longer term, the impact of Covid-19 and its consequences on the global economy, is likely to underpin Manolete's strong growth prospects for the foreseeable future".

 

For further information, please contact:

 

Manolete Partners Plc via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

 

Peel Hunt (NOMAD and Sole Broker) +44 (0)20 7418 8900

James Britton

Rishi Shah

Duncan Littlejohns

 

Instinctif Partners (Financial PR)

Tim Linacre +44 (0)7949 939237

 


[1] Includes one case with a discounted revenue of £9.3m as disclosed in the Interim results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZQLFLFFLZBBQ
Date   Source Headline
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results
3rd Nov 20217:00 amRNSNotice of Half Year Results
6th Oct 20217:00 amRNSTrading Update
1st Oct 20212:52 pmRNSDirector/PDMR Dealings
22nd Sep 20219:57 amRNSResult of AGM
21st Sep 20217:00 amRNSAGM Statement
9th Jul 20214:30 pmRNSPosting of Annual Report and Notice of AGM
25th Jun 20217:00 amRNSManolete Partners ranked in Band 1 by Chambers
24th Jun 202112:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20217:00 amRNSFull Year Results
23rd Jun 20217:00 amRNSAppointment of Chairman Designate
14th Jun 202110:29 amRNSNotice of Full Year Results
1st Mar 202112:45 pmRNSTR-1: Notification of Major Holdings
23rd Feb 20217:00 amRNSUpdated Investor Presentation
22nd Feb 20217:00 amRNSInvestor Presentation
10th Feb 202111:28 amRNSTR-1: Notification of Major Holdings
10th Feb 20217:00 amRNSDirector/PDMR Dealings
9th Feb 20217:00 amRNSDirector/PDMR Dealings
1st Feb 20217:21 amRNSDirector/PDMR Dealings
29th Jan 20217:00 amRNSDirector/PDMR Dealings
28th Jan 20211:09 pmRNSTR-1: Notification of Major Holdings
28th Jan 202111:24 amRNSTR-1: Notification of Major Holdings
27th Jan 20212:42 pmRNSTR-1: Notification of Major Holdings
26th Jan 20214:40 pmRNSSecond Price Monitoring Extn
26th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20212:47 pmRNSQ3 Trading Update
5th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Dec 20202:02 pmRNSTR-1: Notification of Major Holdings
18th Nov 202010:29 amRNSLarge Case Update
12th Nov 20207:00 amRNSFurther Significant Case Completion
10th Nov 20207:00 amRNSHalf Year Results
3rd Nov 20202:52 pmRNSNotice of Half Year Results
1st Oct 20207:00 amRNSGrant of Share Options
22nd Sep 202011:51 amRNSResult of AGM
17th Sep 20207:00 amRNSDirector/PDMR Shareholding
15th Sep 20204:23 pmRNSTrading Update - Significant Case Completion
24th Jul 20205:20 pmRNSNotification of Major Holdings
15th Jul 20204:02 pmRNSNotification of Major Holdings
14th Jul 20207:00 amRNSResponse to Article Published by ShareProphets
13th Jul 20204:41 pmRNSSecond Price Monitoring Extn
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:46 pmRNSPosting of Annual Report and Notice of AGM
13th Jul 20209:05 amRNSSecond Price Monitoring Extn
13th Jul 20209:00 amRNSPrice Monitoring Extension
3rd Jul 20207:05 amRNSAppointment of Joint Broker
3rd Jul 20207:00 amRNSFull Year Results
30th Jun 20203:56 pmRNSNotice of Full Year Results
29th Jun 202011:08 amRNSUpdate on Judgment
22nd Jun 20207:00 amRNSChange of Date for Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.